Prof Otis Brawley discusses the issues surrounding prostate cancer screening and the treatment decisions that may follow
watchProf Loidl and Prof Bjartell discuss the Prostate-Specific Antigen (PSA) and it's role in screening and monitoring prostate cancer and how it should be used in current clinical practice.
watch